Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C23H22FN7O3 |
Molecular Weight | 463.4643 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COCCOC1=CC2=C(C=CN([C@H](C)C3=NN=C4N3C=C(C=C4F)C5=CN(C)N=C5)C2=O)N=C1
InChI
InChIKey=DWHXUGDWKAIASB-CQSZACIVSA-N
InChI=1S/C23H22FN7O3/c1-14(30-5-4-20-18(23(30)32)9-17(11-25-20)34-7-6-33-3)21-27-28-22-19(24)8-15(13-31(21)22)16-10-26-29(2)12-16/h4-5,8-14H,6-7H2,1-3H3/t14-/m1/s1
Molecular Formula | C23H22FN7O3 |
Molecular Weight | 463.4643 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 01:47:20 UTC 2023
by
admin
on
Sat Dec 16 01:47:20 UTC 2023
|
Record UNII |
08WG8S0L8D
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL3545212
Created by
admin on Sat Dec 16 01:47:20 UTC 2023 , Edited by admin on Sat Dec 16 01:47:20 UTC 2023
|
PRIMARY | |||
|
1173699-31-4
Created by
admin on Sat Dec 16 01:47:20 UTC 2023 , Edited by admin on Sat Dec 16 01:47:20 UTC 2023
|
PRIMARY | |||
|
44181686
Created by
admin on Sat Dec 16 01:47:20 UTC 2023 , Edited by admin on Sat Dec 16 01:47:20 UTC 2023
|
PRIMARY | |||
|
C95203
Created by
admin on Sat Dec 16 01:47:20 UTC 2023 , Edited by admin on Sat Dec 16 01:47:20 UTC 2023
|
PRIMARY | |||
|
DB15639
Created by
admin on Sat Dec 16 01:47:20 UTC 2023 , Edited by admin on Sat Dec 16 01:47:20 UTC 2023
|
PRIMARY | |||
|
100000175796
Created by
admin on Sat Dec 16 01:47:20 UTC 2023 , Edited by admin on Sat Dec 16 01:47:20 UTC 2023
|
PRIMARY | |||
|
08WG8S0L8D
Created by
admin on Sat Dec 16 01:47:20 UTC 2023 , Edited by admin on Sat Dec 16 01:47:20 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
Little efficacy shown in Phase II trials.
IC50
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SOLVATE->ANHYDROUS |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|